| Literature DB >> 31867320 |
Yan Li1, Liyin Wen1, Tianwei Tan1, Yongqin Lv1.
Abstract
The main challenges in multienzymatic cascade reactions for CO2 reduction are the lowEntities:
Keywords: CO2 reduction; improved conversion; metal-organic framework; sequential co-immobilization of enzymes; storage of CO2
Year: 2019 PMID: 31867320 PMCID: PMC6908815 DOI: 10.3389/fbioe.2019.00394
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Scheme 1Schematic illustration of the preparation of HKUST-1@amine-MIL-101(Cr)-based multienzymes for the reduction of adsorbed CO2.
Figure 1Transmission electron microscopy (TEM) image of MIL-101(Cr) (a), and scanning electron microscopy (SEM) images of MIL-101(Cr) (b), HMD-MIL-101(Cr) (c), cystamine-MIL-101(Cr) (d), PEI(50)-MIL-101(Cr) (e), and PEI(100)-MIL-101(Cr) (f).
Figure 2(A) X-ray diffraction patterns of MIL-101(Cr) simulated, HMD-MIL-101(Cr), PEI(100)-MIL-101(Cr), cystamine-MIL-101(Cr), and PEI(50)-MIL-101(Cr), and (B) X-ray diffraction patterns of HKUST-1 simulated, HKUST-1@HMD-MIL-101(Cr), HKUST-1@cystamine-MIL-101(Cr), HKUST-1@PEI(100)-MIL-101(Cr), and HKUST-1@ PEI(50)-MIL-101(Cr).
Figure 3X-ray photoelectron spectroscopy measurements of MIL-101(Cr) (A), HMD-MIL-101(Cr) (B), cystamine-MIL-101(Cr) (C), PEI(50)-MIL-101(Cr) (D), and PEI(100)-MIL-101(Cr) (E).
Figure 4Nitrogen adsorption/desorption isotherms (A) and pore size distributions (B) of MIL-101(Cr) and its amine-functionalized counterparts. (C) CO2 adsorption capacities of HKUST-1, MIL-101(Cr), PEI(50)-MIL-101(Cr), PEI(100)-MIL-101(Cr), cystamine-MIL-101(Cr), and HMD-MIL-101(Cr). (D) CO2 adsorption capacities of HKUST-1@PEI(50)-MIL-101(Cr), HKUST-1@PEI(100)-MIL-101(Cr), HKUST-1@cystamine-MIL-101(Cr), and HKUST-1@HMD-MIL-101(Cr).
The BET surface area and pore volume of MIL-101(Cr) and amine-MIL-101(Cr).
| MIL-101(Cr) | 2,477 | 1.44 |
| HMD-MIL-101(Cr) | 1,922 | 1.08 |
| Cystamine-MIL-101(Cr) | 1,011 | 0.68 |
| PEI(50)-MIL-101(Cr) | 1,314 | 0.72 |
| PEI(100)-MIL-101(Cr) | 1,160 | 0.56 |
The adsorption capacity of amine-MIL-101(Cr) for CO2 at 5 bar and 298 K.
| MIL-101(Cr) | 1.88 |
| HMD-MIL-101(Cr) | 2.57 |
| Cystamine-MIL-101(Cr) | 3.11 |
| PEI(50)-MIL-101(Cr) | 4.48 |
| PEI(100)-MIL-101(Cr) | 8.25 |
| HKUST-1 | 2.17 |
| HKUST-1@HMD-MIL-101(Cr) | 0.65 |
| HKUST-1@Cystamine-MIL-101(Cr) | 0.80 |
| HKUST-1@PEI(50)-MIL-101(Cr) | 0.94 |
| HKUST-1@PEI(100)-MIL-101(Cr) | 1.14 |
Figure 5Transmission electron microscopy images of HKUST-1@HMD-MIL-101(Cr) (a), HKUST-1@cystamine-MIL-101(Cr) (b), HKUST-1@PEI(50)-MIL-101(Cr) (c), and HKUST-1@PEI(100)-MIL-101(Cr) (d). Scanning electron microscopy (SEM) images of HKUST-1@HMD-MIL-101(Cr) (e), HKUST-1@cystamine-MIL-101(Cr) (f), HKUST-1@PEI(50)-MIL-101(Cr) (g), HKUST-1@PEI(100)-MIL-101(Cr) (h), immobilized enzymes in HKUST-1@PEI(100)-MIL-101(Cr) (i), and immobilized enzymes in HKUST-1@PEI(100)-MIL-101(Cr) after repeated use for 10 cycles (j).
Figure 6(A) Production amount of HCOOH catalyzed by HKUST-1@HMD-MIL-101(Cr), HKUST-1@cystamine-MIL-101(Cr), HKUST-1@PEI(50)-MIL-101(Cr), and HKUST-1@PEI(100)-MIL-101(Cr) immobilized enzyme systems. (B) Formic acid production at different reaction times. (C) Production amount of HCOOH catalyzed by HKUST-1@PEI(100)-MIL-101(Cr) immobilized enzymes using adsorbed CO2 as substrate, HKUST-1@PEI(100)-MIL-101(Cr) immobilized enzymes using bubbled CO2 as substrate, and free enzymes using bubbled CO2 as substrate. (D) 13C NMR spectrum of formic acid produced from HKUST-1@PEI(100)-MIL-101(Cr) immobilized enzymes using adsorbed CO2 as substrate. (E) Reusability of HKUST-1@PEI(100)-MIL-101(Cr) immobilized enzymes with respect to the number of reaction cycles in which the adsorbed CO2 was used as substrate.
HCOOH production at different NADH concentration.
| 0.5 | 1.77 | 353.9 |
| 1 | 2.83 | 283.3 |
| 2 | 3.21 | 160.6 |
| 2.8 | 5.04 | 179.8 |
Comparison of the NADH-based methanol or HCOOH yield produced using HKUST-1@PEI(100)-MIL-101(Cr) immobilized enzymes and other immobilized systems reported in published literatures.
| Polystyrene particles | FateDH, FaldDH, ADH, GDH | 50 μM | 52.6 | El-Zahab et al., |
| GelCSi hybrid microcapsules | FateDH, FaldDH, YADH | 50 mM | 71.6 | Wang D. et al., |
| Porous silica sol-gel | FateDH, FaldDH, ADH | 50 μM | 91.2 | Obert and Dave, |
| Alginate-silica hybrid gel | FateDH, FaldDH, ADH | 940 μM | 98.1 | Xu et al., |
| Hollow nanofiber membrane | FateDH, FaldDH, ADH | 1 mM | 103.2 | Ji et al., |
| ZIF-8 | FateDH,GDH, FaldDH, ADH | 10 mM | 40.2 | Zhu et al., |
| Titania nanoparticle | FateDH, FaldDH, | 50 mM | 92.7 | Shi et al., |
| Millimeter-scale gel bead | FateDH, FaldDH, ADH | 0.1 mM | 22.5 | Jiang et al., |
| HKUST-1@PEI(100)-MIL-101(Cr) | CA, FateDH, GDH | 0.1 mM | 353.9 | This work |
Formate dehydrogenase (FateDH), formaldehyde dehydrogenase (FaldDH), alcohol dehydrogenase (ADH), glutamate dehydrogenase (GDH), and yeast alcohol dehydrogenase (YADH).
The final product was methanol.
The final product was formic acid.